There is an increased risk for developing gestational diabetes (GDM) for PCOS women compared to those without. This is due to an increased prevalence of insulin resistance, a problem which affects 65 – 80% of PCOS women.
Inofolic Alpha and Inofolic AlphaPlus are suitable to take throughout pregnancy and can reduce the risk of developing gestational diabetes by reducing the impact of insulin resistance.
